Thelansis

Acute Low Back Pain Market Outlook Thelansis’s “Acute Low Back Pain Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Acute Low Back Pain treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). Key business questions answered: How can drug development and lifecycle management strategies be optimized across G8 markets (US, EU5, Japan, and China)? How large is the patient population in terms of incidence, prevalence, segments, and those receiving drug treatments? What is the 10-year market outlook for sales and patient share? Which events will have the greatest impact on the market’s trajectory? What...

Acute Low Back Pain Market Outlook Thelansis’s “Acute Low Back Pain Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Acute Low Back Pain treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). Acute Low Back Pain Overview Acute Low back pain is pain, muscle tension, or stiffness, localised below the costal margin and above the inferior gluteal folds, with or without referred or radicular leg pain persists for <12 weeks. Acute LBP may be self-limiting, although there is a high recurrence rate with less-painful symptoms recurring in 50% to 80% of people within one year of the initial episode; 1 year later, as many as 33% of people sti...

  Acute Low back pain is pain, muscle tension, or stiffness, localised below the costal margin and above the inferior gluteal folds, with or without referred or radicular leg pain persists for <12 weeks. Acute LBP may be self-limiting, although there is a high recurrence rate with less-painful symptoms recurring in 50% to 80% of people within one year of the initial episode; 1 year later, as many as 33% of people still experience moderate-intensity pain and 15% experience severe pain. This type of pain is most common between the ages of 35 to 55 years. Symptoms, pathology, and radiological appearances are poorly correlated. An anatomical source of the pain cannot be identified in about 80% of people. Acute LBP is the 2nd most common symptomatic reason for office visits to primary care physicians and the most common sense for office visits to orthopaedic surgeons, neurosurgeons, and occupational medicine physicians. Recurrence of LBP is common; 60-80% of patients experience recur...